Kymriah
Ended Awarded
- Contract number
- 36C24921N0323
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $283,556
Award facts
- Contract value 100% obligated
- $283,555.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Hanover, NJ 07936, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of Kymriah, a specialized cell therapy cancer treatment, to the Department of Veterans Affairs (VA) through a Blanket Purchase Agreement (BPA) under Novartis Pharmaceuticals Corporation's Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. The BPA, valued at $283,555.92, was issued by the VA's Veterans Integrated Service Network 9 and has a completion date of January 29, 2021.
Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical goods, holds a $5.4 billion FSS contract for pharmaceuticals and drugs, which extends through August 2025. Under this and other indefinite-delivery, indefinite-quantity (IDIQ) contracts, Novartis has provided various specialty drug products, including Kymriah, to VA medical facilities nationwide to support the agency's healthcare programs for veterans. The contract award did not utilize any set-aside designations.
Quick answers
Who was awarded contract 36C24921N0323?
36C24921N0323 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 9 (Veterans Health Administration) on January 26, 2021.
How much is contract 36C24921N0323 worth?
The government has obligated $283,556 on 36C24921N0323.
Is contract 36C24921N0323 an order under another contract?
Yes. 36C24921N0323 is a BPA call under 36F79720D0180-36E79720A0019, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24921N0323 competed?
The extent of competition for 36C24921N0323 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award